Table 3.
Recently published meta-analysis comparing DEB-TACE to cTACE
| Citation | Total studies | Study design | Patients | Surv | OR | AE |
|---|---|---|---|---|---|---|
| Zhou et al (2014)10 | 9 | 5 RCTs 3 retrospective |
830 | Better | Better | Same |
| Xie et al (2015)12 | 6 | 4 RCTs 0 retrospective |
652 | Same | Better | Same |
| Hui et al (2015)11 | 4 | 4 RCTs | 527 | NA | Same | Better |
| Facciorusso et al (2016)14 | 12 | 4 RCTs 6 retrospective |
1449 | Same | Same | Same |
| Chen et al (2017)13 | 16 | 4 RCTs 9 retrospective |
1832 | Better | Same | Same |
Abbreviations: AE adverse events; cTACE, conventional transarterial chemoembolization; DEB-TACE, drug-eluting beads transarterial chemoembolization; NA, not available; OR, objective response; RCTs, randomized controlled trials; Surv, survival.